Visium Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Visium Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-154,751	Closed	-$2.16M	–	526
2016 Q1	$2.16M	Sell	154,751 -320,249	-67%	-$4.7M	0.04%	381
2015 Q4	$9.69M	Sell	475,000 -469,700	-50%	-$7.25M	0.15%	168
2015 Q3	$12.4M	Sell	944,700 -15,300	-2%	-$254K	0.17%	126
2015 Q2	$14.7M	Sell	960,000 -40,000	-4%	-$767K	0.21%	95
2015 Q1	$20M	Buy	1,000,000 +307,375	+44%	+$6.87M	0.29%	71
2014 Q4	$14.6M	Hold	692,625	–	–	0.21%	88
2014 Q3	$12.9M	Buy	692,625 +300,000	+76%	+$5.43M	0.19%	112
2014 Q2	$9.07M	Buy	+392,625	New	+$6.92M	0.14%	144

Other funds holding AGTC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Visium Asset Management's AGTC Position: Q2 2016 in Review

Visium Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2016, closing a stake of 154,751 shares — an estimated $2.16M sold.

Visium Asset Management first reported a position in AGTC in Q2 2014 and held it in 8 quarters. The position peaked at $20M in Q1 2015. 94 funds tracked by Wall St. Rank hold AGTC as of Q2 2016.

Visium Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 154,751 Applied Genetic Technologies Corporation shares in Q2 2016, an estimated $2.16M.
Visium Asset Management first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 8 quarters.
Visium Asset Management's Applied Genetic Technologies Corporation position peaked at $20M in Q1 2015.
94 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.